LifeStance Health Group
Stock Forecast, Prediction & Price Target

	Passed			Analyst forecast
Metric	12/31/2021	12/31/2022	12/31/2023	12/31/2025	12/31/2026
Revenue % change YoY	$667.51M N/A	$859.54M 28.76%	$1.05B 22.81%	Avg: $1.37B Low: $1.33B High: $1.41B avg. 30.62%	Avg: $1.56B Low: $1.53B High: $1.59B avg. 13.16%
Net Income % change YoY	$-307.19M N/A	$-215.56M 29.82%	$-186.26M 13.59%	Avg: $-74.48M Low: $-102.88M High: $-58.79M avg. 60.00%	Avg: $-39.78M Low: $-63.54M High: $-25.72M avg. 46.59%
EBITDA % change YoY	$-233.68M N/A	$-141.19M 39.57%	$-104.92M 25.68%	Avg: $-108.11M Low: $-111.25M High: $-104.98M avg. -3.04%	Avg: $-122.34M Low: $-124.75M High: $-120.51M avg. -13.16%
EPS % change YoY	-$0.94 N/A	-$0.61 35.10%	-$0.51 16.39%	Avg: -$0.21 Low: -$0.28 High: -$0.16 avg. 58.55%	Avg: -$0.12 Low: -$0.17 High: -$0.07 avg. 44.65%
Operating Expenses % change YoY	$487.86M N/A	$447.19M -8.33%	$491.23M 9.84%	Avg: $702.45M Low: $682.09M High: $722.81M avg. 42.99%	Avg: $794.90M Low: $782.99M High: $810.55M avg. 13.16%

FAQ

Wall Street analysts estimate the annual average earnings growth rate of 53.30% in 2025-2026.

We have gathered data from 5 analysts. Their low estimate is -102.88M, average is -74.48M and high is -58.79M.

Wall Street analysts forecast annual average revenue growth of 21.89% in 2025-2026.

We have gathered data from 6 analysts. Their low revenue estimate is $1.33B, average is $1.37B and high is $1.41B.

Wall Street analysts forecast annual average earnings growth of 51.60% in 2025-2026.

We have gathered data from 5 analysts. Their low earnings per share estimate is -$0.28, average is -$0.21 and high is $-0.16.